전립샘암 발견율에 대한 역학적 특성 = Epidemiologic Characteristics of Prostate Cancer Detection

다국어 초록 (Multilingual Abstract)

Purpose: The prevalence of prostate cancer is increasing in the general population. This study aimed to evaluate the epidemiologic characteristics of the prostate cancer detection rate.
Materials and Methods: We analyzed data from patients who underwent transrectal ultrasound-guided prostate biopsy and who were newly diagnosed with prostate cancer from 2005 to 2006 in Korea. These data were based on National Health Insurance statistics. We also analyzed the data of patients who underwent transrectal ultrasound-guided prostate biopsy and were newly diagnosed with prostate cancer in our institution from 2005 to 2007.
Results: According to the data of the National Health Insurance, the detection rates of prostate cancer were 45.8% in 2005 and 43.1% in 2006. These results were not actual cancer detection rates. According to the data from our institution, the cancer detection rate ranged from 24.8% to 25.9% compared with the 15.5% to 23% cancer detection rate reported by other Korean studies. We analyzed the reasons for this difference in detection rates and suggest that the difference is because a suggestive diagnosis is useful and is unchanged until the diagnosis is confirmed.
Conclusions: The prevalence of prostate cancer is increasing more rapidly than that of other major cancers. The detection rate of prostate cancer in Korean patients who underwent transrectal ultrasound-guided prostate biopsy was inferior to that in Caucasians. Also, some patients were detected without proper screening or biopsy and were thus diagnosed as having advanced or metastatic prostatic cancer. We need a good co- relationship between National Health Insurance and the cancer registration project for real detection of prostate cancer.

다국어 초록 (Multilingual Abstract)

Purpose: The prevalence of prostate cancer is increasing in the general population. This study aimed to evaluate the epidemiologic characteristics of the prostate cancer detection rate.
Materials and Methods: We analyzed data from patients who underwent transrectal ultrasound-guided prostate biopsy and who were newly diagnosed with prostate cancer from 2005 to 2006 in Korea. These data were based on National Health Insurance statistics. We also analyzed the data of patients who underwent transrectal ultrasound-guided prostate biopsy and were newly diagnosed with prostate cancer in our institution from 2005 to 2007.
Results: According to the data of the National Health Insurance, the detection rates of prostate cancer were 45.8% in 2005 and 43.1% in 2006. These results were not actual cancer detection rates. According to the data from our institution, the cancer detection rate ranged from 24.8% to 25.9% compared with the 15.5% to 23% cancer detection rate reported by other Korean studies. We analyzed the reasons for this difference in detection rates and suggest that the difference is because a suggestive diagnosis is useful and is unchanged until the diagnosis is confirmed.
Conclusions: The prevalence of prostate cancer is increasing more rapidly than that of other major cancers. The detection rate of prostate cancer in Korean patients who underwent transrectal ultrasound-guided prostate biopsy was inferior to that in Caucasians. Also, some patients were detected without proper screening or biopsy and were thus diagnosed as having advanced or metastatic prostatic cancer. We need a good co- relationship between National Health Insurance and the cancer registration project for real detection of prostate cancer.

참고문헌 (Reference)

1 이승찬, "혈청 PSA 4-10ng/ml인 환자에서 전립선암 진단을 위한 PSA밀도, PSA속도 그리고 Percent free PSA의 유용성" 대한비뇨기과학회 45 (45): 747-752, 2004

2 정병창, "한국인 전립선암 진단에서 전립선 특이항원, 전립선 특이항원 밀도, 직장 수지검사 및 경직장 초음파촬영술의 선별검사로서의 임상적 유용성" 대한비뇨기과학회 43 (43): 14-18, 2002

3 성도환, "전립선특이항원치가 4.0-10.0ng/ml인 한국남성에서 나이와 전립선 용적이 전립선암 발견율에 미치는 영향: 다기관, 후향적 연구" 대한비뇨기과학회 47 (47): 353-357, 2006

4 권종규, "전립선특이항원 선별검사 도입에 따른 전립선암의 임상병리학적 특성의 변화" 대한비뇨기과학회 50 (50): 439-444, 2009

5 송강현, "전립선암 환자의 진단 시기에 따른 임상적 요소들의 변화" 대한비뇨기과학회 48 (48): 574-578, 2007

6 Jung JY, "The outcome of TRUS-guided sextant biopsy according to prostate volume" 41 : 505-511, 2000

7 Pu YS, "The 18th international symposium: controversies in prostate cancer diagnosis and treatment" 35 : 680-689, 2005

8 Meshref AW, "Role of prostate-specific antigen density after applying age-specific prostate-specific antigen reference ranges" 45 : 972-979, 1995

9 Park SK, "Rising prostate cancer rates in South Korea" 66 : 1285-1291, 2006

10 Schröder FH, "Prostate cancer detection at low prostate specific antigen" 163 : 806-812, 2000

11 Yamamoto S, "Dose transrectal ultrasound guided eight-core prostate biopsy improve cancer detection rates in patients with prostate- specific antigen levels of 4.1-10 ng/mL?" 11 : 386-391, 2004

12 Kobayashi T, "Detection of prostate cancer in men with prostate-specific antigen levels of 2.0 to 4.0 ng/mL equivalent to that in men with 4.1 to 10.0 ng/mL in a Japanese population" 63 : 727-731, 2004

13 Morote J, "Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng/ml" 158 : 502-504, 1997

14 Catalona WJ, "Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men" 151 : 1283-1290, 1994

15 Jemal A, "Cancer statistics, 2004" 54 : 8-29, 2004

16 Kyu-Won Jung, "Cancer Survival in Korea 1993-2002: A Population-Based Study" 대한의학회 22 (22): 5-10, 2007